967 related articles for article (PubMed ID: 19406869)
1. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.
Basso C; Thiene G; Mackey-Bojack S; Frigo AC; Corrado D; Maron BJ
Eur Heart J; 2009 Jul; 30(13):1627-34. PubMed ID: 19406869
[TBL] [Abstract][Full Text] [Related]
2. Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death.
Yetman AT; McCrindle BW; MacDonald C; Freedom RM; Gow R
N Engl J Med; 1998 Oct; 339(17):1201-9. PubMed ID: 9780340
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and mode of death in isolated hypertrophic cardiomyopathy in children.
Decker JA; Rossano JW; Smith EO; Cannon B; Clunie SK; Gates C; Jefferies JL; Kim JJ; Price JF; Dreyer WJ; Towbin JA; Denfield SW
J Am Coll Cardiol; 2009 Jul; 54(3):250-4. PubMed ID: 19589438
[TBL] [Abstract][Full Text] [Related]
5. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
[TBL] [Abstract][Full Text] [Related]
7. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.
Elliott PM; Gimeno JR; Tomé MT; Shah J; Ward D; Thaman R; Mogensen J; McKenna WJ
Eur Heart J; 2006 Aug; 27(16):1933-41. PubMed ID: 16754630
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
Sadoul N; de Chillou C; Aliot E; McKenna WJ
Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
Pokorski RJ
J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
[TBL] [Abstract][Full Text] [Related]
11. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
[TBL] [Abstract][Full Text] [Related]
12. Morphologic evidence for "small vessel disease" in patients with hypertrophic cardiomyopathy.
Maron BJ; Wolfson JK; Epstein SE; Roberts WC
Z Kardiol; 1987; 76 Suppl 3():91-100. PubMed ID: 3433879
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of cardiac arrhythmia in patients with hypertrophic cardiomyopathy].
Wang Y; Cui YH; Wang DW
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):401-4. PubMed ID: 15061995
[TBL] [Abstract][Full Text] [Related]
14. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging.
Kwon DH; Smedira NG; Popovic ZB; Lytle BW; Setser RM; Thamilarasan M; Schoenhagen P; Flamm SD; Lever HM; Desai MY
Heart; 2009 Nov; 95(21):1784-91. PubMed ID: 19549621
[TBL] [Abstract][Full Text] [Related]
15. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
[TBL] [Abstract][Full Text] [Related]
16. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients.
Biagini E; Coccolo F; Ferlito M; Perugini E; Rocchi G; Bacchi-Reggiani L; Lofiego C; Boriani G; Prandstraller D; Picchio FM; Branzi A; Rapezzi C
J Am Coll Cardiol; 2005 Oct; 46(8):1543-50. PubMed ID: 16226182
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy].
Göktekin O; Ritsushi K; Matsumoto K; Hiroshi M
Anadolu Kardiyol Derg; 2002 Sep; 2(3):226-30. PubMed ID: 12223331
[TBL] [Abstract][Full Text] [Related]
18. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
Maron MS; Olivotto I; Harrigan C; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron BJ
Circulation; 2011 Jul; 124(1):40-7. PubMed ID: 21670234
[TBL] [Abstract][Full Text] [Related]
19. Age- and gender-specific mortality rates in childhood hypertrophic cardiomyopathy.
Ostman-Smith I; Wettrell G; Keeton B; Holmgren D; Ergander U; Gould S; Bowker C; Verdicchio M
Eur Heart J; 2008 May; 29(9):1160-7. PubMed ID: 18385119
[TBL] [Abstract][Full Text] [Related]
20. [Hypertrophic cardiomyopathy: mode of death and pathological findings].
Fujiwara H; Tanaka M; Onodera T; Kawai C
J Cardiol Suppl; 1987; 16():3-8. PubMed ID: 3509681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]